Human Rights and Global Pharma Converge
In this article, based on the annual public oration of the Australian Centre for Health Law Research at QUT, Michael Kirby explores the interaction between the discovery of life saving and health preserving pharmaceuticals and international intellectual property (IP) law. He explains the investigation of this topic in a number of transnational bodies in which he has worked. He outlines the specific benefits of antiretroviral medicines for treatment of HIV causing AIDS and HCV (Hepatitis C). He explains the advent of the United Nations Sustainable Development Goals in 2015 and his participation in a High Level Panel created by the UN Secretary General to ensure their attainment. The article closes with some suggested further directions in international IP law and health access.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Articles in this journal are published under the Creative Commons Attribution Licence (CC-BY). This is to achieve more legal certainty about what readers can do with published articles, and thus a wider dissemination and archiving, which in turn makes publishing with this journal more valuable for authors.